Boston Scientific (NYSE: BSX)
Boston Scientific Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Boston Scientific Company Info
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.
News & Analysis
Better Buy: Medtronic or Boston Scientific?
Which one of these medical device makers is better poised for a breakout year?
This Medical Device Maker Will Be Well Positioned Post COVID
The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.
3 Top Healthcare Stocks to Buy in August
New products mean solid revenue may be ahead for these companies.
Is Boston Scientific Stock a Buy?
Newly released products will drive revenue growth, but will they benefit shareholders?
[TIMESENSITIVE] Why These Top Medical Device Stocks Have Fallen by Double Digits So Far in 2020
High demand for a single product can't sustain an industry.
Which Stock Will Bounce Back Best: Medtronic or Boston Scientific?
The pandemic has slowed sales for the two medical device companies. Which stock is ready to rise when medical procedures return?
Boston Scientific Stock Rises on Sales Increase, Positive Management Outlook
A sharp decline in medical procedures caused a drop in first quarter profit.
Boston Scientific Begins Selling Low-Cost Ventilator Alternative
The company's Coventor will retail for under $1,000.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.